Kazia Therapeutics Limited (KZIA) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access KZIA Annual Balance Sheets →
By examining balance sheet figures across successive periods, users can identify shifts in Kazia Therapeutics Limited's financial structure and capital allocation.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2025)
0 0 0 (Jun 30 2024)
Assets
Cash And Cash Equivalents4.35
Cash & Short-term Investments4.00
Trade & Other Current Receivables (IFRS combined total)0.21
Other Current Assets0.59
Total Current Assets4.93
Intangible Assets0.00
Other Assets, Noncurrent1.13
Total Assets6.06
Liabilities
Accounts Payable0.00
Shortterm Borrowings0.40
Other Liabilities, Current13.66
Total Current Liabilities14.05
Total Long-term Debt0.00
Deferred Tax Liabilities, Net LI0.27
Other liabilities, Noncurrent0.04
Total Liabilities14.36
Stockholders' Equity
Common Stockholder's Equity-8.30
Total Stockholder's Equity-8.30
Liabilities & Stockholder's Equity6.06
4 historic quarters locked

Sign in to unlock the full Kazia Therapeutics Limited balance sheet history.

About Kazia Therapeutics Ltd Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 20-F filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 20-F (Period: 20250630)
  • Filed with the SEC: November 7, 2025
  • Source: d908386d20f.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-25-272284

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.